Publications
Progress towards effective vaccines for Chlamydia trachomatis
Collar, Amanda L.; Frietze, Kathryn M.. Progress towards effective vaccines for Chlamydia trachomatis. Current Opinion in Infectious Diseases ():10.1097/QCO.0000000000001075, November 21, 2024. | DOI: 10.1097/QCO.0000000000001075
Romano IG, Core SB, Lee NR, Mowry C, Van Rompay KKA, Huang Y, Chackerian B, Frietze KM. A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood. Vaccine. 2023 Dec 29:S0264-410X(23)01533-5. doi: 10.1016/j.vaccine.2023.12.077. PMID: 38160131.
Ensuring equity with pre-clinical planning for chlamydia vaccines
Collar AL, Clarke TN, Jamus AN, Frietze KM. Ensuring equity with pre-clinical planning for chlamydia vaccines. NPJ Vaccines. 2023 Sep 6;8(1):131. doi: 10.1038/s41541-023-00726-7. PMID: 37673890; PMCID: PMC10482967.
Leo J, Core SB, Frietze KM. Streamlined Data Analysis Pipeline for Deep Sequence-Coupled Biopanning Identification of Pathogen-Specific Antibody Responses in Serum. Methods Mol Biol. 2023;2681:399-406. doi: 10.1007/978-1-0716-3279-6_23. PubMed PMID: 37405661.
Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design
Warner NL, Core SB, Frietze KM. Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design. Vaccines (Basel). 2022 Nov 27;10(12):2028. doi: 10.3390/vaccines10122028. PMID: 36560438; PMCID: PMC9784660.
Medical Counseling on Sexual Enrichment Aids: Women's Preferences and Medical Practitioner Expertise
Collar AL, Rishel Brakey H, Fuentes JE, Frietze KM. Medical Counseling on Sexual Enrichment Aids: Women's Preferences and Medical Practitioner Expertise. Obstet Gynecol. 2022 Aug 3. doi: 10.1097/AOG.0000000000004892. Epub ahead of print. PMID: 35926212.
Collar AL, Linville AC, Core SB, Frietze KM. Epitope-Based Vaccines against the Chlamydia trachomatis Major Outer Membrane Protein Variable Domain 4 Elicit Protection in Mice. Vaccines (Basel). 2022 May 30;10(6):875. doi: 10.3390/vaccines10060875. PMID: 35746483; PMCID: PMC9227494.
Collar AL, Fuentes JE, Rishel Brakey H, Frietze KM. Sexual Enrichment Aids: A Mixed Methods Study Evaluating Use, Hygiene, and Risk Perception among Women. J Sex Res. 2021 Dec 17:1-10. doi: 10.1080/00224499.2021.2015568. Epub ahead of print. PMID: 34919465.
Warner NL, Frietze KM. Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1. Vaccines (Basel). 2021 Jul 2;9(7):726. doi: 10.3390/vaccines9070726. PMID: 34358143; PMCID: PMC8310087.
Warner NL, Linville AC, Core SB, Moreno B, Pascale JM, Peabody DS, Chackerian B, Frietze KM. Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum. Viruses. 2020 Sep 30;12(10):1114. doi: 10.3390/v12101114. PMID: 33008118; PMCID: PMC7600589.
Collar AL, Linville AC, Core SB, Wheeler CM, Geisler WM, Peabody DS, Chackerian B, Frietze KM. Antibodies to Variable Domain 4 Linear Epitopes of the Chlamydia trachomatis Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women. mSphere. 2020 Sep 23;5(5):e00654-20. doi: 10.1128/mSphere.00654-20. PMID: 32968007; PMCID: PMC7568647.
Assessing Antibody Specificity in Human Serum Using Deep Sequence-Coupled Biopanning.
Frietze KM, Core SB, Linville A, Chackerian B, Peabody DS. Assessing Antibody Specificity in Human Serum Using Deep Sequence-Coupled Biopanning. Methods Mol Biol. 2020;2070:157-171. doi: 10.1007/978-1-4939-9853-1_9. PMID: 31625095.
Frietze KM, Lijek R, Chackerian B. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis. Expert Rev Vaccines. 2018 Nov;17(11):959-966. doi: 10.1080/14760584.2018.1534587. Epub 2018 Oct 20. PMID: 30300019; PMCID: PMC6246778.
Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses.
Frietze KM, Pascale JM, Moreno B, Chackerian B, Peabody DS. Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses. PLoS One. 2017 Feb 2;12(2):e0171511. doi: 10.1371/journal.pone.0171511. PMID: 28152075; PMCID: PMC5289605.
Engineering virus-like particles as vaccine platforms.
Frietze KM, Peabody DS, Chackerian B. Engineering virus-like particles as vaccine platforms. Curr Opin Virol. 2016 Jun;18:44-9. doi: 10.1016/j.coviro.2016.03.001. Epub 2016 Mar 29. PMID: 27039982; PMCID: PMC4983494.
Moving towards a new class of vaccines for non-infectious chronic diseases.
Chackerian B, Frietze KM. Moving towards a new class of vaccines for non-infectious chronic diseases. Expert Rev Vaccines. 2016 May;15(5):561-3. doi: 10.1586/14760584.2016.1159136. Epub 2016 Mar 16. PMID: 26919571.
Frietze KM, Roden RB, Lee JH, Shi Y, Peabody DS, Chackerian B. Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning Platform. Cancer Immunol Res. 2016 Feb;4(2):157-64. doi: 10.1158/2326-6066.CIR-15-0165. Epub 2015 Nov 20. PMID: 26589767; PMCID: PMC4740227.
Frietze KM, Campos SK, Kajon AE. No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection. BMC Res Notes. 2012 Aug 11;5:429. doi: 10.1186/1756-0500-5-429. PMID: 22882760; PMCID: PMC3500273.
Frietze KM, Campos SK, Kajon AE. Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization. J Virol. 2010 Nov;84(21):11310-22. doi: 10.1128/JVI.00512-10. Epub 2010 Aug 25. PMID: 20739542; PMCID: PMC2953142.